AVROBIO
INDUSTRY LEADER
Background
The gene therapy industry has worked through difficult technical challenges and clinical setbacks in the past decade to reach its current position on the brink of widespread application across a range of rare diseases. AVROBIO has been at the forefront in pushing the field forward, and TBC has provided the company with comprehensive strategic and tactical communications support to highlight that leadership.
Clinical
- Digital analytics and optimization
- Media strategy and execution
- Messaging development
- Social media/Digital marketing
- Strategic counsel and planning
- Thought leadership
Strategy
With deep expertise in the science of gene therapy and the clinical, regulatory and commercial issues surrounding it, we have employed media relations, thought leadership, digital communications and other tactics to emphasize AVROBIO’s differentiated platform, advanced analytics, commercial-ready manufacturing system and other assets. Throughout the relationship we have been close advisors to AVROBIO’s CEO and the rest of its executive team on strategy, positioning and messaging.
Thought leadership focus
Thought leadership has been an integral activity to demonstrate AVROBIO’s excellence in the gene therapy space. The TBC team has developed extensive content, including written blog posts and presentation decks to support speaking engagements, in collaboration with AVROBIO executives. Topics covered have included clinical trial design, analytics, industry trends, manufacturing process development and others.
